{"id":188,"date":"2007-09-03T00:04:03","date_gmt":"2007-09-03T05:04:03","guid":{"rendered":"http:\/\/blogs.law.harvard.edu\/politicshiv\/2007\/09\/03\/quackery-over-the-us-labor-day-we"},"modified":"2007-09-03T00:11:04","modified_gmt":"2007-09-03T05:11:04","slug":"quackery-over-the-us-labor-day-weekend","status":"publish","type":"post","link":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/2007\/09\/03\/quackery-over-the-us-labor-day-weekend\/","title":{"rendered":"Renewed institutional support for innovation in HIV prevention"},"content":{"rendered":"<p>This is reposted in full from the Lancet blog post of Aug 23th, <a href=\"http:\/\/blogs.thelancet.com\/archive\/2007\/08\/23\/us14-million-grant-for-hiv-prevention-campaign\">&#8220;US$14 million grant for HIV prevention campaign&#8221;<\/a>.<\/p>\n<p>The AIDS Vaccine Advocacy Coalition is launching a new organization<br \/>\nto promote the development of a wide variety of HIV prevention<br \/>\nstrategies, including microbicides and oral preventive drugs.<\/p>\n<p>The launch of the new organization, called The HIV Prevention<br \/>\nResearch Advocacy Network, was announced by AVAC Tuesdsy, Aug 21 in<br \/>\nSeattle at the AIDS Vaccine 2007 conference.<\/p>\n<p>The initiative will be funded by five-year, US$14 million grant from the Bill &amp; Melinda Gates Foundation<\/p>\n<p>According to the press release announcing the network\u2019s launch, the organization will:<\/p>\n<p>\u2022Develop international advocacy partnerships that support both the<br \/>\nneeds of communities involved in research and a global advocacy<br \/>\nmovement for HIV prevention research.<\/p>\n<p>\u2022\tTranslate complex scientific ideas to communities AND translate community needs and perceptions to the scientific community.<\/p>\n<p>\u2022\tWork to hold both research agencies and advocates accountable for accelerating ethical prevention research and development.<\/p>\n<p>\u2022 Help ensure that communities, policymakers, and civil society have<br \/>\nrealistic expectations about HIV prevention research and specific<br \/>\nclinical trials.<\/p>\n<p>\u2022\tWork closely with other groups conducting HIV prevention research advocacy, including microbicide advocacy groups.<\/p>\n<p>AVAC also released it annual report, which provides an overview of<br \/>\nthe state of HIV vaccine research today. Of particular interest is a<br \/>\nsection that looks at the slow uptake of both male circumcision as an<br \/>\nHIV prevention strategy and the vaccine for human papilloma Virus<br \/>\n(HPV). These case studies, the report argues, holds lessons for those<br \/>\nseeking to implement other prevention strategies.<\/p>\n<p>To visit AVAC site and download the new report go to: <a href=\"http:\/\/www.avac.org\/\" target=\"_blank\">http:\/\/www.avac.org\/<\/a><\/p>\n<p>To visit the AIDS Vaccine 2007 conference website go to: <a href=\"http:\/\/www.hivvaccineenterprise.org\/conference\/index.html\" target=\"_blank\">www.hivvaccineenterprise.org\/conference\/index.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is reposted in full from the Lancet blog post of Aug 23th, &#8220;US$14 million grant for HIV prevention campaign&#8221;. The AIDS Vaccine Advocacy Coalition is launching a new organization to promote the development of a wide variety of HIV prevention strategies, including microbicides and oral preventive drugs. The launch of the new organization, called [&hellip;]<\/p>\n","protected":false},"author":712,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1758,1759,1761,1105,1110],"tags":[],"class_list":["post-188","post","type-post","status-publish","format-standard","hentry","category-academic-groups","category-advocacy","category-researchresources","category-resources","category-science-and-technology"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts\/188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/users\/712"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/comments?post=188"}],"version-history":[{"count":0,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts\/188\/revisions"}],"wp:attachment":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/media?parent=188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/categories?post=188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/tags?post=188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}